We are developing a new generation of medicines by harnessing the body’s natural mechanism of RNA interference. Nasdaq:SLN Guidelines: https://bit.ly/3iYc2sP
Location: United Kingdom, England, London
Member count: 11-50
Total raised: $40M
Founded date: 1994

Investors 1

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
25.05.2021-$40M-marketscre...

Mentions in press and media 39

DateTitleDescriptionCategoryAuthorSource
22.02.2022Another bi...Silence Therapeutics became th...-Max Gelmanendpts.com...
05.01.2022Silence Th...Silence Therapeutics to Partic...--globenewsw...
12.12.2021New Data f...New Data from SLN124 Healthy V...--globenewsw...
01.12.2021Silence Th...1 December 2021 LONDON, Silen...--globenewsw...
01.12.2021Silence Th...1 December 2021 LONDON, Silen...--marketscre...
30.11.2021Silence Th...Silence Therapeutics Begins Ex...--marketscre...
26.11.2021Silence Th...Silence Therapeutics plc: Upda...--marketscre...
11.11.2021Silence Th...Silence Therapeutics to Presen...--globenewsw...
08.11.2021Silence Th...LONDON, Silence Therapeutics p...--marketscre...
05.11.2021Silence Th...Silence Therapeutics Welcomes ...--marketscre...
Show more